BioNTech SE - ADR vs Dover Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Dover Corp trades at $208.79 (market cap $28.07B). The key difference: Dover Corp is the larger of the two by market cap, and Dover Corp pays a 1.01% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | DOV | |
|---|---|---|
Market Cap | $23.31B | $28.07B |
Sector | Health | Industrials |
52-Week High | $119.34 | $233.31 |
52-Week Low | $83.89 | $161.16 |
Enterprise Value | $6.60B | $29.58B |
Dividend Yield | — | 1.01% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →